- 67.8k views
How to become a global radiologist through Global Radiology Training Programme (GRTP)
.Introducing the Global Radiology Training Programme (GRTP), India's first integrated radiology programme designed for students and working professionals. Join us for an exclusive live Q&A session featuring Dr. Sreenivasa Raju Kalidindi, Director of ARI Academy and CEO & Medical Director of Apollo Radiology International, along with Dr. Subhasis Chakraborty, Course Director and Professor of Paediatric Radiology & Consultant Paediatric Radiologist at Oxford, UK. Discover how GRTP can help you become a global radiologist and unlock new career opportunities. Dr. Sreenivasa Raju and Dr. Subhasis Chakraborty will discuss the programme's benefits, and outcomes, and answer your questions. GRTP is designed to meet the needs of Radiologists in training and Junior Radiologists seeking skill enhancement and better career prospects. Participants can undertake the programme alongside their MD or DNB or directly after completion, enabling them to pursue additional exams like EDiR, FRCR, MiCR, and more. This multiple qualification approach enhances professional credentials. By bringing international training standards and renowned faculty to Indian radiologists, GRTP eliminates the need for scarce and competitive training positions abroad. Acquiring additional qualifications such as FRCR expands job opportunities globally, including the UK, Middle East, Australia, and beyond. For those seeking specialist training abroad, GRTP strengthens resumes and enhances competitiveness. Completing GRTP provides Indian radiologists with a competitive edge in the global job market. Don't miss this opportunity to elevate your radiology career with GRTP. Join us for the live Q&A session and gain valuable insights.
About the Speaker
Dr. Sreenivasa Raju Kalidindi Director, ARI Academy, CEO & Medical Director·Apollo Radiology International, India
Dr. Subhasis Chakraborty Course Director, Professor of Paediatric Radiology & Consultant Paediatric
Upcoming Case Discussions
H. pylori Treatment with PYELRA®: Best Practices
PYLERA® is a medication used for the treatment of Helicobacter pylori (H. pylori) infection, a common cause of stomach ulcers and gastritis. It contains a combination of three active ingredients: bismuth subcitrate potassium, metronidazole, and tetracycline. This combination works synergistically to eradicate H. pylori bacteria and reduce associated symptoms. Treatment with PYLERA® typically involves taking multiple capsules four times a day for a specified duration, as prescribed by a healthcare provider. It is important to follow the treatment regimen as directed and to discuss potential side effects
Pneumonia in Children
Pneumonia in children is often caused by viral or bacterial infections, leading to inflammation of the lungs. Symptoms may include cough, fever, rapid breathing, and chest pain. Diagnosis typically involves physical examination, chest X-ray, and sometimes blood tests or other imaging studies. Treatment may include antibiotics for bacterial pneumonia, supportive care such as rest, fluids, and fever management, and in severe cases, hospitalization for oxygen therapy and close monitoring. Vaccination against common pathogens like Streptococcus pneumoniae and Haemophilus influenzae type b can help prevent pneumonia in children.
Patient Centric Care in Critical Care
Patient-centric care in critical care is a holistic approach that places the patient at the center of medical decision-making and treatment processes. It prioritizes the individual's preferences, values, and needs, considering not only their medical condition but also their emotional and psychological well-being. This approach involves clear communication, shared decision-making, and active involvement of patients and their families in care planning. Healthcare providers strive to deliver personalized care that respects the patient's dignity, autonomy, and cultural beliefs, aiming to optimize outcomes and enhance overall quality of life.
Medical Nutrition Therapy in Diabetes
Medical nutrition therapy (MNT) is a cornerstone in the management of diabetes, focusing on individualized dietary plans tailored to the patient's specific needs and goals. It emphasizes a balanced intake of macronutrients, including carbohydrates, proteins, and fats, to achieve optimal blood glucose control while promoting overall health and well-being. MNT aims to stabilize blood sugar levels, prevent complications, and improve quality of life through careful monitoring of food intake, portion control, and timing of meals. Additionally, MNT educates patients on carbohydrate counting, glycemic index, and meal timing to help them make informed choices and better manage their condition. Collaborative efforts between patients, healthcare providers, and registered dietitians play a vital role in implementing and sustaining effective MNT strategies tailored to each individual's lifestyle and dietary preferences, thereby enhancing diabetes management and long-term health outcomes.
HIPEC for Ovarian Cancer
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has emerged as a promising treatment modality for advanced ovarian cancer, offering a multifaceted approach to combat this challenging disease. In HIPEC, heated chemotherapy is circulated throughout the abdominal cavity following cytoreductive surgery, targeting residual cancer cells and microscopic disease not removed by surgery alone. This localized delivery of chemotherapy at elevated temperatures enhances drug penetration, increases cytotoxicity, and disrupts tumor cell repair mechanisms. Consequently, HIPEC not only addresses macroscopic disease but also targets microscopic metastases, potentially reducing recurrence rates and improving overall survival outcomes. Despite its promising results, HIPEC requires specialized expertise and is typically reserved for select patients with advanced ovarian cancer who can tolerate aggressive surgical and chemotherapeutic approaches. Ongoing research aims to further refine patient selection criteria, optimize treatment protocols, and assess long-term outcomes to establish HIPEC's role in the comprehensive management of ovarian cancer.